In Ovo and In Silico Evaluation of the Anti-Angiogenic Potential of Syringin
Open Access
- 1 November 2020
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 14, 5189-5204
Abstract
Introduction: Cancer is considered as one of the deadliest human diseases today. Angiogenesis, the propagation of new blood vessels from pre-existing vasculature, is a critical step in the progression of cancer as it is essential in the growth and metastasis of tumors. Hence, suppression of angiogenesis is a promising approach in cancer therapy. Syringin, a phenylpropanoid glycoside with a molecular formula of C17H24O9, has been found to exhibit chemopreventive effects. However, its anti-angiogenic activity and the underlying mechanism of action are still unknown. Methods: In this work, in ovo chorioallantoic membrane (CAM) assay has been conducted to evaluate the effect of syringin on neovascularization. Additionally, reverse molecular docking studies have been performed in order to identify the probable enzyme targets in the angiogenesis pathway. Results: Treatment with syringin showed significant dose-dependent inhibition of blood vessel length and junctions in the CAM of duck eggs; the anti-angiogenic activity of syringin at 100 μM and 200 μM is comparable with 200 μM of the positive control celecoxib. The results of reverse docking studies indicate that syringin binds the strongest to dihydrofolate reductase (DHFR) and, to some extent, with transforming growth factor-beta receptor type 1 (TGF-βR1), vascular endothelial growth factor receptor 2 (VEGFR2), and matrix metalloproteinase-2 (MMP-2). Furthermore, ADMET models revealed that syringin potentially possesses excellent pharmacokinetic and toxicity profiles. Conclusion: This study demonstrates the potential of syringin as an anti-angiogenic agent and elicits further investigations to establish its application in cancer suppression.Keywords
This publication has 93 references indexed in Scilit:
- Cytotoxic phenolic glycosides from Boschniakia himalaicaChemistry of Natural Compounds, 2012
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Molecular Mediators of AngiogenesisJournal of Burn Care & Research, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasisHistochemistry and Cell Biology, 2008
- Zinc‐Binding Groups Modulate Selective Inhibition of MMPsChemMedChem, 2008
- MMPs as therapeutic targets—Still a viable option?Seminars in Cell & Developmental Biology, 2008
- Discovery and development of sorafenib: a multikinase inhibitor for treating cancerNature Reviews Drug Discovery, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Studies on Constituents with Cytotoxic Activity from the Stem Bark of Syringa velutina.Chemical and Pharmaceutical Bulletin, 1999